| Katherine Ann Fergin, | |
|
2300 N Edward, Decatur, IL 62526 | |
| (217) 876-8121 | |
| (217) 876-2261 |
| Full Name | Katherine Ann Fergin |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 29 Years |
| Location | 2300 N Edward, Decatur, Illinois |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124113337 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 046230 (Illinois) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Taylorville Memorial Hospital | 8022914704 | 12 |
News Archive
VIVUS, Inc. today announced that additional data on Qnexa(TM), an investigational drug candidate for obesity, was presented at the 27th annual scientific meeting of The Obesity Society (TOS) in Washington D.C. Wesley W. Day, PhD, vice president of clinical development at VIVUS, presented the additional data from the company's two year-long phase 3 obesity trials during the Pharmacotherapy Update portion of the pre-conference on October 24, 2009.
A recent meta-analysis of five major breast cancer trials has confirmed that combination treatment with the antibody trastuzumab and chemotherapy improves survival in women with operable HER-2 positive breast cancer.
Pre-menopausal South Asian women could be more at risk of developing osteoporosis in later life than white Caucasian women, a new study in the Journal Bone reports.
NPS MedicineWise has published a new edition of RADAR, including a review of glycopyrronium (Seebri Breezhaler), a new medicine for the treatment of chronic obstructive pulmonary disease (COPD).
› Verified 2 days ago
| Entity Name | Taylorville Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518170729 PECOS PAC ID: 8022914704 Enrollment ID: O20031211001049 |
News Archive
VIVUS, Inc. today announced that additional data on Qnexa(TM), an investigational drug candidate for obesity, was presented at the 27th annual scientific meeting of The Obesity Society (TOS) in Washington D.C. Wesley W. Day, PhD, vice president of clinical development at VIVUS, presented the additional data from the company's two year-long phase 3 obesity trials during the Pharmacotherapy Update portion of the pre-conference on October 24, 2009.
A recent meta-analysis of five major breast cancer trials has confirmed that combination treatment with the antibody trastuzumab and chemotherapy improves survival in women with operable HER-2 positive breast cancer.
Pre-menopausal South Asian women could be more at risk of developing osteoporosis in later life than white Caucasian women, a new study in the Journal Bone reports.
NPS MedicineWise has published a new edition of RADAR, including a review of glycopyrronium (Seebri Breezhaler), a new medicine for the treatment of chronic obstructive pulmonary disease (COPD).
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Katherine Ann Fergin, 2300 N Edward, Decatur, IL 62526 Ph: (217) 876-8121 | Katherine Ann Fergin, 2300 N Edward, Decatur, IL 62526 Ph: (217) 876-8121 |
News Archive
VIVUS, Inc. today announced that additional data on Qnexa(TM), an investigational drug candidate for obesity, was presented at the 27th annual scientific meeting of The Obesity Society (TOS) in Washington D.C. Wesley W. Day, PhD, vice president of clinical development at VIVUS, presented the additional data from the company's two year-long phase 3 obesity trials during the Pharmacotherapy Update portion of the pre-conference on October 24, 2009.
A recent meta-analysis of five major breast cancer trials has confirmed that combination treatment with the antibody trastuzumab and chemotherapy improves survival in women with operable HER-2 positive breast cancer.
Pre-menopausal South Asian women could be more at risk of developing osteoporosis in later life than white Caucasian women, a new study in the Journal Bone reports.
NPS MedicineWise has published a new edition of RADAR, including a review of glycopyrronium (Seebri Breezhaler), a new medicine for the treatment of chronic obstructive pulmonary disease (COPD).
› Verified 2 days ago
Cullen Whicker, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2300 N Edward St, Decatur, IL 62526 Phone: 217-876-2575 | |
Janet L Gaither, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 899 E Lake Shore Dr Apt 2c, Decatur, IL 62521 Phone: 217-428-7596 Fax: 217-788-7071 | |
Brittney L Jeffery, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2300 N Edward St, Decatur, IL 62526 Phone: 217-876-2275 Fax: 217-876-2281 | |
Mrs. Lindsay Beth Beery, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2300 N Edward St, Decatur, IL 62526 Phone: 217-876-8121 Fax: 217-876-2261 | |
Mary A Beam, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1800 E Lake Shore Dr, Decatur, IL 62521 Phone: 217-464-2729 Fax: 217-464-1693 | |
Chelsey M Clark, DNP, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2300 N Edward St, Decatur, IL 62526 Phone: 217-876-8121 |